Concomitant herbal medicine and Antiretroviral Therapy (ART) use among HIV patients in Western Uganda: A cross-sectional analysis of magnitude and patterns of use, associated factors and impact on ART adherence

被引:35
|
作者
Lubinga, S. J. [1 ]
Kintu, A. [2 ]
Atuhaire, J. [1 ]
Asiimwe, S. [2 ,3 ]
机构
[1] Mbarara Univ Sci & Technol, Dept Pharm, Mbarara, Uganda
[2] Kabwohe Clin Res Ctr KCRC, Clin Trials Unit, Bushenyi, Uganda
[3] Univ Georgia, Dept Epidemiol & Biostat, Paul D Coverdell Ctr Biomed & Hlth Sci, Athens, GA 30602 USA
关键词
herbal medicine; Antiretroviral Therapy; adherence; Uganda; ALTERNATIVE MEDICINE; COMPLEMENTARY; HAART; CARE;
D O I
10.1080/09540121.2011.648600
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Use of herbal medicines among patients receiving Anti-retroviral Therapy (ART) remains by far an uncharacterised phenomenon in Africa and Uganda specifically. We evaluated the use of herbal medicines among patients on ART at the HIV clinic of Mbarara Regional Referral Hospital (MRRH), examined factors associated with their concomitant use and their impact on ART adherence. This was a cross-sectional study among 334 systematically sampled patients receiving ART at the HIV clinic of MRRH from February to April 2010. We collected data on patient demographics, clinical characteristics, perceptions of quality of care received, self-perceived health status, information on ART received, herbal medicines use and ART adherence. Study outcomes were concomitant herbal medicine and ART use, and ART adherence. Descriptive analysis and logistic regression were conducted using Stata10.0. Close to half, 155 (46.4%) reported concomitant herbal medicines and ART use, with 133 (39.8%) using herbal medicines at least once daily. Most (71.6%) used herbal medicines to treat HIV-related symptoms. A majority (92.3%) reported that the doctors were unaware of their use of herbal medicines, 68.5% citing its minimal importance to the attending physician. Most frequently used herbs were Aloe vera (25%) and Vernonia amygdalina (21%). Time since start of ART (OR 1.14 95% CI: 1.01-1.28, for each one year increase), number of ART side effects reported (>= 3 vs. <= 1, OR 2.20 95% CI 1.13-4.26) and self-perceived health status (Good vs. Poor, OR 0.31 95% CI 0.12-0.79) were independently associated with concomitant herbal medicine and ART use. Concomitant herbal medicine and ART use was not associated with poor ART adherence (OR 0.85 95% CI 0.47-1.53). There is widespread concomitant herbal medicines and ART use among our patients, with no association to poor ART adherence. Patients appear to use these therapies to complement as opposed to substituting ART.
引用
收藏
页码:1375 / 1383
页数:9
相关论文
共 50 条
  • [41] Association of Traditional Chinese Medicine Use With Adherence to Prescribed Western Rheumatic Medications Among Chinese American Patients: A Cross-Sectional Survey
    Sun, Kai
    Szymonifka, Jackie
    Tian, Henghe
    Chang, Yaju
    Leng, Jennifer C.
    Mandl, Lisa A.
    ARTHRITIS CARE & RESEARCH, 2020, 72 (10) : 1474 - 1480
  • [42] Herbal Medicine Use and Determinant Factors Among HIV/AIDS Patients on Antiretroviral Therapy in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia
    Shiferaw, Abebe
    Baye, Assefa Mulu
    Amogne, Wondwossen
    Feyissa, Mauro
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2020, 12 : 941 - 949
  • [43] Perceptions of HIV patients on the use of cell phones as a tool to improve their antiretroviral adherence in Northwest, Ethiopia: a cross-sectional study
    Sefefe Birhanu Tizie
    Atsede Mazengia Shiferaw
    Miftah Abdella Beshir
    Muluken Belachew Mengistie
    Sayih Mehari Degualem
    Bayou Tilahun Assaye
    BMC Public Health, 23
  • [44] Perceptions of HIV patients on the use of cell phones as a tool to improve their antiretroviral adherence in Northwest, Ethiopia: a cross-sectional study
    Tizie, Sefefe Birhanu
    Shiferaw, Atsede Mazengia
    Beshir, Miftah Abdella
    Mengistie, Muluken Belachew
    Degualem, Sayih Mehari
    Assaye, Bayou Tilahun
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [45] Factors associated with adherence to Antiretroviral Therapy (ART) among adult people living with HIV and attending their clinical care, Eastern Ethiopia
    Letta, Shiferaw
    Demissie, Asrat
    Oljira, Lemessa
    Dessie, Yadeta
    BMC INTERNATIONAL HEALTH AND HUMAN RIGHTS, 2015, 15
  • [46] Adherence to Combined Antiretroviral Therapy and Associated Factors Among People Living with HIV Attending Nekemte Specialized Hospital, Oromia, Ethiopia: A Cross-Sectional Study
    Ejigu, Mulu
    Desalegn, Zelalem
    Mulatu, Befirdu
    Mosisa, Getu
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2020, 12 : 97 - 106
  • [47] Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique
    Pati, Rituparna
    Lahuerta, Maria
    Elul, Batya
    Okamura, Mie
    Alvim, Maria Fernanda
    Schackman, Bruce
    Bang, Heejung
    Fernandes, Rufino
    Assan, Americo
    Lima, Josue
    Nash, Denis
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2013, 16
  • [48] Prevalence and Factors Associated with Hypertension Among HIV Positive Patients on Antiretroviral Therapy: A Hospital-Based Cross-Sectional Study in Rwanda
    Uwanyirigira, Donatha
    Biracyaza, Emmanuel
    Uzabakiriho, Innocent
    Omolo, Jared
    Hakizayezu, Francois
    Nzayirambaho, Manasse
    VASCULAR HEALTH AND RISK MANAGEMENT, 2023, 19 : 857 - 870
  • [49] Prevalence and correlates of herbal medicine use among Anti-Retroviral Therapy (ART) clients at Queen Elizabeth Central Hospital (QECH), Blantyre Malawi: a cross-sectional study
    Mbali, Hawah
    Sithole, Jessie Jane Khaki
    Nyondo-Mipando, Alinane Linda
    MALAWI MEDICAL JOURNAL, 2021, 33 (03) : 153 - 158
  • [50] Prevalence of Complementary and Alternative Medicine Use and Its Associated Factors among Iranian Diabetic Patients: A Cross-Sectional Study
    Ghorat, Fereshteh
    Mosavat, Seyed Hamdollah
    Hadigheh, Samaneh
    Kouhpayeh, Seyed Amin
    Naghizadeh, Mohammad Mehdi
    Rashidi, Ali Akbar
    Hashempur, Mohammad Hashem
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2024, 100